Learn about this progressive, multi-system disease
The information on this site is intended for healthcare professionals only.
The Hereditary ATTR Amyloidosis Learning Zone is an educational resource for healthcare professionals that provides medical information on the epidemiology, pathophysiology, diagnosis and treatment. Test your knowledge on cardiac and neurological symptoms with our expert-led eLearning modules.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
Developed by EPG Health for Medthority.com, with all content provided by Alnylam Pharmaceuticals. Learning Zone sponsored and funded by Alnylam Pharmaceuticals. Please note that this material is intended for healthcare professionals only.
Date of preparation: August 2020 │ TTR02-CEMEA-00288 │ TTR02-UKI-00148.
Additional resources are available at www.hattramyloidosis.co.uk
© Copyright 2020